Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: 49 | Vintage Vibes

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Independent UK

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

Zepbound is expected to be available in the U.S. by the end of the year.

Fortune

Overweight Teens Face Higher Cancer Risk, Study Shows

Obesity in adolescence linked to up to 17 different cancers, raising concerns about long-term health consequences.

Zenger

From analysis to the latest developments in health,
read the most diverse news in one place.

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

Weight-loss drug Wegovy faces high demand, limited supply, and tricky health care systems to navigate.

Fortune

Ultra-Processed Food-Cancer Link: Study Says Higher Risk Not Just Due To Obesity

The study has found that eating 10% more ultra-processed food raises the risk of head and neck cancer by 23% and the risk of esophageal adenocarcinoma by 24%.

Medical Daily

No more Thanksgiving 'food orgy'? New obesity medications change how users think of holiday meals

Holiday meals may be changing for millions of Americans struggling with obesity and taking a new generation of weight-loss drugs

The Independent UK

Revealed: obesity jab maker discussed targeting benefit claimants with UK government

Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Barchart

'As bad as 15 cigarettes a day': WHO declares loneliness a global health concern

The effects of loneliness can be greater than obesity and smoking

Evening Standard

Here's what happens when cats get too fat (it involves acidic poop)

Obesity is wreaking havoc on cats' digestive systems, causing "significant changes" in their gut microbial compositions and giving them highly acidic poop.

LiveScience

Mounjaro has been authorised for weight loss in the UK – here's how it compares to Wegovy

The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorised by the UK’s medicines regulation authority for use in weight loss and weight management. The decision was made on the same day the US Food and Drug Administration (FDA) approved a version of…

The Conversation

Initiative launched to assist college students in Chennai stay healthy and in shape

M.V. Diabetes & M. Viswanathan Diabetes Research Centre launched Chennai Slim & Fit 2.0 to educate college students on healthy lifestyle & prevent obesity. 6,000 school students were followed in 2007, with findings published in 2013. Nina Reddy, Joint MD of Savera Hotel, urged people to look after themselves &…

The Hindu

Insecure renting ages you faster than owning a home, unemployment or obesity. Better housing policy can change this

People’s experiences of private rental housing are linked to faster biological ageing, our recent research finds.

The Conversation

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

ICMR-NIN scientists find alarming obesity levels in Telangana and Andhra Pradesh

ICMR-NIN study finds alarming obesity rates in Hyderabad & Telugu States; 47.7% urban adults in Telangana & 46.7% rural adults in AP obese. Over 11% urban & 6% rural adults suffer from hypertension; 5% in both regions have diabetes. Adults aged 40-59 & those engaged in clerical/skilled/semi-skilled occupations have higher…

The Independent UK

FDA approves new weight loss drug

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

The Guardian - UK

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

WEKU

FDA approves Zepbound, a new obesity drug that will take on Wegovy

Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Diabetes drug authorised for weight management and loss – MHRA

Obese and overweight adults could have access to Tirzepatide – also known as Mounjaro – if it receives further approval.

The Independent UK

FDA approves new version of diabetes drug Mounjaro for weight loss

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

The Independent UK

Drugs aren't required to be tested in people who are obese. Here's why that's a problem

More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies

The Independent UK

Patients more likely to lose weight if GPs frame options as ‘good news’ – study

People were less likely to sign up to weight-loss programmes when doctors talked about obesity in a negative way, researchers found.

Fortune

Novo Nordisk isn’t alone: Sales of Wegovy rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze

Drugs helping weight-loss like Novo Nordisk's Wegovy and Eli Lilly's Mounjaro drove blockbuster sales for the pharma giants in the third quarter.

The Guardian - UK

Sales soar at Danish firm behind weight-loss drug semaglutide

Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company

The Independent UK

High insulin levels linked to increased risk of pancreatic cancer

People with obesity and type 2 diabetes are more likely to get pancreatic cancer, research has found

1 … 48 49 50 51

People

Lars Fruergaard Jørgensen

18 stories

Alison Edelman

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

the University of Oxford

179 stories

the Department of Health

110 stories

Wegovy

73 stories

the US Food and Drug Administration

71 stories

Eli Lilly and Company

60 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.